Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 2:15 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1801–1824 of 3,077 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intracranial Vascular Disorders Clear all

Conditions: Carotid Stenosis
Interventions: Abciximab; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Liver Failure, Ischemic Stroke
Interventions: Transcranial Doppler; Diagnostic Test
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2025
U.S. locations: 3
States / cities: Davis, California • San Francisco, California • Atlanta, Georgia

Conditions: Ischemic Stroke
Interventions: Sildenafil (Viagra), Usual care; Drug · Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Aphasia, Stroke
Interventions: Adaptive Spacing Condition, High-Item Non-Adaptive Spacing Condition, Low-Item Non-Adaptive Spacing Condition; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Subarachnoid Hemorrhage, Hypertension
Interventions: Clevidipine butyrate injectable emulsion; Drug
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Stroke, Upper Extremity Paresis, Hemiplegia
Interventions: Active conventional tDCS montage plus CCFES, Active unconventional tDCS montage plus CCFES, Sham tDCS plus CCFES, CCFES with Occupational Therapy; Device · Behavioral
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 21 Years to 90 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Stroke, Muscle Spasticity
Interventions: Botulinum Toxin Type A; Biological
Lead sponsor: Allergan; Industry
Eligibility: 21 Years and older
Enrollment: 279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Stroke, Cardiovascular Disease
Interventions: Motivational Interviewing Intervention Arm, Control Brochure Arm; Behavioral · Other
Lead sponsor: Washington State University; Other
Eligibility: 11 Years and older
Enrollment: 458 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 4
States / cities: Phoenix, Arizona • Oklahoma City, Oklahoma • Eagle Butte, South Dakota + 1 more

Conditions: Stroke, Patent Foramen Ovale, PFO
Interventions: Investigational PFO Closure Device, Standard of Care PFO Closure Device; Device
Lead sponsor: Occlutech International AB; Industry
Eligibility: 18 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 27
States / cities: Phoenix, Arizona • Stanford, California • Thousand Oaks, California + 20 more

Conditions: Stroke
Interventions: Telmisartan, Metformin, Cilostazol; Drug
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 21 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Depression
Interventions: NSI-189 Phosphate, microcrystalline cellulose capsules; Drug
Lead sponsor: Neuralstem Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Glendale, California

Conditions: ICH - Intracerebral Hemorrhage, IVH- Intraventricular Hemorrhage, TBI Traumatic Brain Injury
Interventions: EVD placement - image-guidance assisted, EVD placement - AR assisted; Device
Lead sponsor: Cooper Norcross Health; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Ischemic Stroke
Interventions: Expiratory muscle strength training, Placebo expiratory training, Measures performed on all subjects, Pulmonary function test, Fluoroscopic swallow study; Behavioral · Drug · Radiation
Lead sponsor: University of Florida; Other
Eligibility: 50 Years to 85 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 2
States / cities: Gainesville, Florida • Jacksonville, Florida

Conditions: Stroke, Cerebrovascular Accident
Interventions: TheraDrive Assistive Device, Rote Therapy versus Fun Therapy; Device · Procedure
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Stroke
Interventions: Not listed
Lead sponsor: Providence VA Medical Center; Federal
Eligibility: 18 Years to 90 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Myocardial Infarction, Hypertension, Stroke
Interventions: BP REACH Intervention; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 35 Years and older
Enrollment: 546 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 4
States / cities: Downey, California • Los Angeles, California • Sylmar, California + 1 more

Conditions: Intracranial Hemorrhage
Interventions: Apollo MIES, Medical Management; Device · Other
Lead sponsor: J. Mocco; Other
Eligibility: 22 Years to 84 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 7
States / cities: Washington D.C., District of Columbia • Louisville, Kentucky • Buffalo, New York + 4 more

Conditions: Injuries, Spinal Cord, CVA (Cerebrovascular Accident), Traumatic Brain Injury, MS (Multiple Sclerosis), Muscle Spasticity, Cerebral Palsy, Spastic
Interventions: Prometra II Programmable Pump - Flowonix Medical; Device
Lead sponsor: Culicchia Neurological Clinic; Other
Eligibility: 22 Years to 85 Years
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Marrero, Louisiana

Conditions: Stroke, Acute, Ischemic Stroke, Acute
Interventions: EndovascularThrombectomy, Endovascular thrombectomy with any FDA-approved device; Procedure · Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Stroke, Acute, Walking, Difficulty
Interventions: Not listed
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Stroke
Interventions: Ranitidine, Placebo, Advanced notification, No advanced notification; Drug · Other
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Acute Ischemic Stroke
Interventions: Enoxaparin sodium; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Stroke
Interventions: Postural counseling; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 90 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Intracranial Hemorrhages, Prematurity
Interventions: Not listed
Lead sponsor: Vanderbilt University; Other
Eligibility: Up to 14 Days
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Nashville, Tennessee

Search by objective public record fields.

Stroke Prevention With Abciximab in Carotid Endarterectomy

NOninVasive Intracranial prEssure From Transcranial doppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients

Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke

Adaptive Trial Scheduling in Naming Treatment for Aphasia

Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage

tDCS + CCFES-mediated Functional Task Practice for Post-stroke Upper Extremity Hemiplegia

Safety Study of Botulinum Toxin Type A for the Treatment of Focal Upper Limb Poststroke Spasticity

Innovative Multigenerational Household Intervention to Reduce Stroke and CVD

Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion

Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke Survivors

Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects

Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization

Cough and Swallow Rehab Following Stroke

Robot-Assisted Motivating Rehabilitation

Deconstructing Post Stroke Hemiparesis

Reducing Blood Pressure in Patients With High Cardiovascular Risk

INVEST Feasibility - Minimally Invasive Endoscopic Surgery With Apollo in Patients With Brain Hemorrhage

Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)

Endovascular Therapy for Large Core Patients With Uncertain Response to Thrombectomy

Cortical Processes During Walking Post-stroke

Extending Acute Stroke Trials to the Aerial Inter-hospital Transfer Setting

PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)

Postural Control and Fine Motor Skills in People With Stroke

Neurophysiology and Anatomy of Severe Intraventricular Hemorrhage (IVH)